Litcius/Paper detail

MRI-based radiomics signature for localized prostate cancer: a new clinical tool for cancer aggressiveness prediction? Sub-study of prospective phase II trial on ultra-hypofractionated radiotherapy (AIRC IG-13218)

Simone Giovanni Gugliandolo, Matteo Pepa, Lars Johannes Isaksson, Giulia Marvaso, Sara Raimondi, Francesca Botta, Sara Gandini, D. Ciardo, Stefania Volpe, Giulia Riva, D.P. Rojas, Dario Zerini, Paola Pricolo, Sarah Alessi, Giuseppe Petralia, Paul Summers, Francesco Alessandro Mistretta, Stefano Luzzago, Federica Cattani, Ottavio De Cobelli, Enrico Cassano, Marta Cremonesi, Massimo Bellomi, Roberto Orecchia, Barbara Alicja Jereczek‐Fossa

2020European Radiology44 citationsDOI

Topics & Concepts

MedicineProstate cancerNeuroradiologyReceiver operating characteristicMagnetic resonance imagingRadiomicsRadiologyStage (stratigraphy)ProstateCancerInternal medicinePsychiatryPaleontologyBiologyNeurologyProstate Cancer Diagnosis and TreatmentRadiomics and Machine Learning in Medical ImagingProstate Cancer Treatment and Research
MRI-based radiomics signature for localized prostate cancer: a new clinical tool for cancer aggressiveness prediction? Sub-study of prospective phase II trial on ultra-hypofractionated radiotherapy (AIRC IG-13218) | Litcius